BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 221 filers reported holding BRIDGEBIO PHARMA INC in Q1 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $18,905,365 | +16.8% | 716,927 | -23.8% | 0.34% | +24.1% |
Q2 2023 | $16,188,227 | +3.7% | 941,176 | 0.0% | 0.27% | -4.2% |
Q1 2023 | $15,604,698 | -64.1% | 941,176 | +32.2% | 0.29% | -50.9% |
Q2 2021 | $43,416,000 | -1.0% | 712,197 | 0.0% | 0.58% | -10.3% |
Q1 2021 | $43,871,000 | – | 712,197 | – | 0.65% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital Management LP | 3,835,722 | $82,353,000 | 42.93% |
Kohlberg Kravis Roberts & Co. L.P. | 36,900,661 | $792,257,000 | 4.46% |
Perceptive Advisors | 6,706,268 | $143,983,000 | 3.88% |
Cormorant Asset Management, LP | 2,617,566 | $56,199,000 | 3.42% |
VIKING GLOBAL INVESTORS LP | 26,620,991 | $571,553,000 | 2.98% |
SC US (TTGP), LTD. | 2,544,738 | $54,636,000 | 2.42% |
HHLR ADVISORS, LTD. | 4,388,690 | $94,225,000 | 1.30% |
Fernwood Investment Management, LLC | 95,200 | $2,044,000 | 1.01% |
AMERICAN INTERNATIONAL GROUP, INC. | 6,746,511 | $144,847,000 | 0.58% |
Ratan Capital Management LP | 46,548 | $999,000 | 0.53% |